In analogy with histo-blood group A antigen, Forssman (Fs) antigen terminates with α3-N-acetylgalactosamine and can be utilized by pathogens as a host receptor in many mammals. However, primates including humans lack Fs synthase activity and have naturally-occurring Fs antibodies in plasma. We investigated individuals with the enigmatic ABO subgroup A pae and found them to be homozygous for common O alleles. Their erythrocytes had no A antigens but instead expressed Fs glycolipids. 
Introduction
Carbohydrate histo-blood group antigens, first recognised on red blood cells (RBCs) in 1900, 1 have been suggested to be part of our innate immune response. 2 Major carbohydrate histo-blood groups in man include the ABO, P1PK, H, Lewis, I and GLOB systems in which glycoproteins and glycolipids carry immunodominant terminal sugars, 3 defining polymorphic antigens. Other mammals also express carbohydrate histo-blood groups such as ABO, 4 fucose-less B antigen (Galili) 5 and Forssman (Fs) 6, 7 but their expression on RBCs varies among species. Although the biological function of polymorphic carbohydrates on RBCs is unresolved these antigens can be utilized as receptors by pathogens [8] [9] [10] [11] and their expression in tissues and bodily secretions is thus believed to reflect microbial selection. 8 In response to blood-group-mimicking glycans on bacterial surfaces, naturally-occurring antibodies with the capacity to neutralize various microorganisms are formed. However, these antibodies also constitute substantial transfusion and transplantation barriers. 3, 12 In 1987, three families with a supposed ABO subgroup named A pae were reported. 13 While Helix pomatia lectin reacted strongly and polyclonal anti-A weakly with RBCs from some family members, monoclonal (MAb) anti-A reagents were later shown to be non-reactive, thus presenting an apparent paradox. The biochemical and genetic background of this enigmatic phenotype has remained unknown, as has its biological consequences. We hypothesized that an explanation may be found by studying the glycolipids of this phenotype. 14 Here we report the identification of Fs glycolipids, normally found only on RBCs of selected non-primate mammals, are strongly expressed on human A pae RBCs. In non-primates, Fs antigen is synthesized by Fs synthase (globoside 3-α-N-acetyl-D-galactosaminyltransferase, EC2.4.1.88), 7 an enzyme homologous to the ABO transferase. We also reveal a genetic polymorphism
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From in the human Fs gene (GBGT1) that alters the enzymatically inactive human protein 15 to its active non-primate counterpart. Overall, these findings qualify Fs as a new histoblood group system with potential implications for both transfusion/transplantation medicine and pathogen susceptibility.
Methods

Samples
Five and three RBC units were collected from each of two unrelated A pae individuals (A pae #1 and A pae #2, respectively) from two of the originally-reported families. 13 
Glycolipids
Glycolipid preparation. Lysed blood units were thawed and total neutral glycolipids with <20 sugar residues were isolated (Supplemental Method 1 where control glycolipid preparations are also described).
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Thin layer chromatography-enzyme immuno assay (TLC-EIA).
The selected method 16 was recently reported to be sensitive for the characterization of weak A subgroups 17 (Supplemental Method 1). A wide range of monoclonal and polyclonal antibodies and lectins were used for immunostaining (Table S1 ).
Structural analysis
Capillary liquid chromatography -electrospray ionization tandem mass spectrometry (LC-ESI/MS-MS). Endoglycoceramidase II from Rhodococcus spp. (TakaraBio Europe
S.A., Gennevilliers, France) was used to release saccharides from ceramide for analysis by LC-ESI/MS-MS as described. 18 
Proton NMR spectroscopy (NMR).
1 H-NMR spectra were acquired on a Varian 600MHz spectrometer at 30°C. Samples were dissolved in dimethylsulfoxide/D 2 O (98:2 v/v) after deuterium exchange. Two-dimensional double quantum-filtered correlated spectroscopy (DQF-COSY) spectra were recorded using the standard pulse sequence.
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Genetic analysis of ABO and GBGT1
ABO genotyping was performed.
20 GBGT1 exons 1-7 were sequenced in 11 humans including two A pae propositi, and compared to Ensembl entry ENST00000372040.
Exon 7 was sequenced in six DNA samples from different non-human primates. Two allele-specific primer (ASP) PCR assays were designed to detect 887G>A and 363C>A. RNA extraction, cDNA preparation and transcript analysis were performed (for details see Supplemental Method 2 and Table S2 ). 
Glycolipid analysis
Based on the hypothesis that another glycolipid than A antigen may be responsible for the A pae phenotype, total neutral glycolipids from A pae #1 and A pae #2 RBC unit lysates were analyzed. Open-column fractionation and pooling resulted in five heterogeneous fractions containing glycolipids with >4 sugars from each donor.
Thin layer chromatography -enzyme immuno assay (TLC-EIA)
Total glycolipids ( Fig.1 ) and open column fractions ( (Fig.2e) .
The non-staining of A pae total glycolipids and concentrated fractions with broadly reactive anti-A reagents (Fig.1d, Fig.S1 ) was indicative of the absence of A glycolipids.
The bands seen with anti-A (A003, Fig.1e ) in A pae #1 were not due to either Fs or A and remain unresolved yet consistent with the weak hemagglutination results observed with A003. Staining with 7 other anti-A MAbs (Table S1 , Fig.S1 ) was unable to detect any bands in the A pae samples. These results strongly suggest that the aberrant bands seen with some anti-A reagents are not due to A antigens. Finally, staining with Lewis MAbs established that both individuals are Le(b+) (Fig.1f) , and, therefore, if blood group A they would be expected to have A-7-1 (ALe b ) glycolipids, 26,27 which were not found.
Overall both A pae samples could be demonstrated to have staining consistent with the presence of Fs, p-Fs, x 2 but absence of A structures.
Structural analysis
The LC-ESI/MS-MS and 1 H-NMR results of both A pae samples were essentially the same. Only A pae #2 results are shown as it had less globoside content (Fig.2a ).
Released oligosaccharides from fraction CM65:35 were analyzed by LC-ESI/MS-MS. (Fig.3b) . Dominant ions in the base sample could be assigned to globoside (P/GbO 4 ), neolactotetraosylceramide (nLc 4 ) and the H-5-2 pentaglycosylceramide, respectively (Fig 3a(i) ). Table S3 . 
Extended serological analysis
Genetic analysis
The sequence of GBGT1 Based on the finding that A pae RBCs carry Fs antigens, exons 1-7 of the GBGT1 gene were sequenced in 11 individuals since this supposed human pseudogene is homologous to mammal Fs synthase genes. 28 No deviations from the GenBank consensus sequence were detected in 9 non-A pae individuals while in both A pae #1 and (Fig.S2) . In addition, A pae #2 was homozygous for a previously noted SNP, 58C>T (Leu20Phe), which shows that A pae has arisen from heterozygosity for different alleles in the two families, with or without 58C>T but including 887G>A. A pae #1 also had another SNP in exon 7, 363C>A, predicting a premature stop codon following residue 120 (Fig.S2 ). Cloning and allele-specific amplification with subsequent sequencing verified that 363C>A and 887G>A are located on different alleles.
Nine non-A pae individuals with different ABO phenotypes conformed to consensus, although 58C>T and 363C>A were detected in five and one, respectively, of the 18 examined alleles. The prevalences of GBGT1-SNPs are given in Table S4 .
Exon 7 of GBGT1 in six different non-human primates was also sequenced, verifying that all had the human consensus 887G, as opposed to non-primates. 15, 28, 29 PCR-ASP assays were designed to screen saliva DNA from members of the two A pae families, and random blood donors for 363C>A and 887G>A (Fig.S2 , Table S4 ). The A pae vs. non-A pae phenotypes defined in the 1987 paper 13 were concordant with the presence of 887G>A (Fig.S3,S4 ).
Transcript analysis
It is unknown if Fs synthase is expressed during hematopoiesis, especially in erythroid cells, although GBGT1-mRNA has been detected in other tissues. 15 We measured transcript levels in buffy coats from four random blood samples of different ABO groups (A 1 /A 2 /B/O) and the two A pae blood samples. Transcripts were readily detected in mRNA preparations from all samples but no apparent quantitative differences were noted, suggesting that lack of Fs is not due to absence of mRNA.
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Transfection of MEG-01
Based on the hypothesis that 887G>A in GBGT1 induces Fs synthesis in A pae individuals, a Fs-negative megakaryoblastic cell line, MEG-01, was co-transfected with the genes encoding P synthase (B3GALNT1) and two allelic forms of Fs synthase (GBGT1). Mutant (887A) but not wild type (887G) GBGT1 resulted in a statistically significant increase in Fs-positive cells (Fig.5 ). This indicates that 887G>A (Arg296Gln) changes the inactive human Fs synthase to become enzymatically active.
Human Fs synthase model
The close homology (45% amino-acid identity) between ABO and GBGT1 permitted creation of a three-dimensional model of the Fs-synthesizing enzyme based on a crystal structure of ABO transferase. 30 The modeled structure of the putative human Fs synthase was generated by threading onto a human group B glycosyltransferase (GTB) variant (PDB entry 2RJ7). The model also shows an overall similarity to the human group A glycosyltransferase (GTA) structure (PDB entry 1LZI), a 3-α-Nacetylgalactosaminyltransferase like Fs synthase (Fig.6a) . Moreover, the catalytically important His301 in GTA maps to the same position as Arg296 in Fs synthase. UDPGalactose (Gal) co-crystallized with the GTB structure can be easily superimposed into the binding pocket of modeled Fs synthase. In sharp contrast to His301 in GTA, none of the preferred side chain rotamers of Arg296 in the Fs synthase model seem well suited to create the critical hydrogen bond to the O6 of the donor-sugar moiety.
Furthermore, assuming that UDP-N-acetylgalactosamine (GalNAc) binds in a similar way to Fs synthase as UDP-Gal binds to GTB, the GalNAc can be easily (Fig.6b) . One reason for this is that the corresponding position of Met-266 in GTB (important for UDP-Gal specificity by sterically preventing binding of UDP-GalNAc 30 ) is glycine in Fs synthase (Gly261), which leaves ample space for GalNAc. The A pae -associated Gln296 mutant is more likely to form a hydrogen bond with O6 of the donor substrate (Fig.6c) , which could explain why the Gln296 enzyme gets activated.
Escherichia coli hemagglutination
P-fimbriae are well-known virulence factors of uropathogenic Escherichia coli. 31 The papG adhesin recognizes the terminal Galα4Gal moiety of P k and P1 blood group glycolipids but also the internal Galα4Gal of P (globoside) antigen. The prsG adhesin recognizes Galα4Gal-containing glycolipids less well but preferentially binds to the Fs structure terminating in GalNAcα3GalNAc. Table 1 shows that neither the parent (HB101) nor the prsG-expressing (HB101.JFK102) 6 In July, 2012, Fs was recognized as a blood-group antigen by ISBT.
The 31 st blood-group system was given the name FORS.
Previous studies have deemed the Fs synthase inactive due to mutations in its catalytic domain encoded by exon 7 of GBGT1. 15 The human protein differs from the canine enzyme by 58 amino-acids but can be reactivated by adding the canine Cterminus to the human N-terminus. 15 The consensus non-primate sequence corresponding to human residue 296 is Gln, while all primate and human (excluding A pae ) sequences code for Arg. GBGT1 has been considered a human pseudogene, together with other homologous genes except ABO in the GT6 superfamily.
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Interestingly, a recent study noted that GBGT1 has not decayed as much as other related pseudogenes, and was therefore predicted to have retained some unknown function. 29 Although speculative, the apparently inactive human consensus form of GBGT1-encoded enzyme (with 296Arg) may have as yet unrecognized enzymatic activity. In contrast, the 296Gln variant described here has become effective at synthesizing Fs, in analogy with the enzyme in many non-primate mammals. The A paeassociated substitution was not found in 256 blood donors but its frequency in other populations around the world remains to be established. In addition to the three originally-reported families (two of which were studied here and surprisingly found to have two different 887G>A-containing alleles), we noted another 887G>A-positive individual (phenotype unknown) in a database (Table S4) . 
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GBGT1 is transcribed in several human tissues but does not appear to result in Fs antigen expression. 15 However, Fs antigen may be expressed in carcinomas 41, 42 and has been suggested to constitute the so-called incompatible A antigen found in nongroup-A individuals with cancer. 42 We demonstrated here for the first time that GBGT1-mRNA is readily detectable in human blood and erythroid bone marrow cultures at levels similar to, if not higher than, ABO-mRNA. 43 This indicates that Fs synthase is likely to be expressed in erythroid progenitors and thus able to make Fs on
RBCs if mutated Arg296Gln.
The carbohydrate histo-blood group systems in man are ancient and the biological pressures that created and maintained them are still largely unknown. 44 The generally accepted belief is that these polymorphisms arose as a consequence of selective pressure exerted by microorganisms. 8 
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Database entries
The new alleles identified were submitted to the EMBL database under the following accession numbers: HE583596 (363C>A), HE583597 (887G>A), HE583598 (58C>T; 887G>A), HE583599 (consensus) and HE583600 (58C>T).
For (a) The GTA structure (orange) (PDB entry 1LZI) has been superimposed onto the human Fs synthase model (green), although this GTA structure has a disordered internal loop and C-terminus. UDP-Gal (grey) from the GTB mutant (PDB entry 2RJ7) was also superimposed onto the figure to highlight the likely location of the donor substrate. The catalytically important His301 in GTA/GTB is shown as sticks and potentially forms a hydrogen bond to the O6 position on the Gal of the UDP-Gal (yellow dashed line). In the human Fs synthase model the Arg296, which corresponds to and overlaps His301 in ABO transferase, is shown as sticks and has adopted a rotamer side chain conformation away from the Gal. In almost any other conformation the Arg296 side chain would be clashing with either nearby residues in the enzyme itself or with the donor. The H-antigen acceptor from the GTB structure is shown as black sticks and the manganese ion as a purple sphere. 
